Predict your next investment

HEALTHCARE | Medical Devices & Equipment
ranier.co.uk

See what CB Insights has to offer

Founded Year

1995

Stage

Other Investors | Alive

About Ranier Technology

CAdisc is a unique, entirely polymeric Total Disc Replacement system for the treatment of degenerative disc disease in the lumbar and cervical spine. CAdisc-Lchar(2122) is designed to relieve pain and restore physiological quality of motion in the lumbar spine.

Ranier Technology Headquarter Location

Greenhouse Park Innovation Centre Newmarket Road

CB5 8AA,

United Kingdom

Latest Ranier Technology News

Device company allegedly sold spinal implants that decayed in patients: 6 insights

Nov 28, 2018

Written by Shayna Korol | November 27, 2018 | Print  | Email The now-defunct Ranier Technology sold spinal implants that allegedly moved and eroded in patients, according to The Guardian . Here are six things to know: 1. Ranier Technology received CE safety marks for its Cadisc-L and Cadisc-C implants, which were certified by the British Standards Institution in 2010 and 2011, respectively. The implants were then marketed to hospitals across Europe for degenerative disc disease treatment. 2. Approximately half of the patients who received the Cadisc-L implants have undergone further surgery after the discs disintegrated or moved in their backs, according to the Implant Files investigation, which was coordinated by the International Consortium of Investigative Journalists and involved The Guardian and BBC's Panorama. 3. A customized Cadisc-L disc was implanted in baboons and detailed in a Orthopaedic Proceedings study. According to the Implant Files investigation, the discs were misplaced in the baboon trials. 4. The results of human trials have not been published but ran for six months before Ranier submitted a CE mark application. 5. Ranier chose to seek approval in Europe before the U.S., allegedly to use the CE mark approval to get FDA clearance. The FDA asked for more data to support the approval application. 6. The company dissolved in 2018. In a statement to The Guardian, Ranier founder Geoffrey Adams said the Cadisc-L devices used in humans were not the same ones used in the baboon trials. He claimed clinical tests in patients had gone well, and the company, "decided unilaterally, and as a precaution, to formally withdraw Cadisc-L from the market, which it did on March 31, 2014," after four patients underwent revision surgery. More articles on devices:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ranier Technology Patents

Ranier Technology has filed 7 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/5/2008

6/23/2015

Bones of the vertebral column, Spinal nerves, Skeletal system, Ligaments of the torso, Orthopedic surgical procedures

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/5/2008

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/23/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Bones of the vertebral column, Spinal nerves, Skeletal system, Ligaments of the torso, Orthopedic surgical procedures

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.